BARCLAYS PLC - ELEVATION ONCOLOGY INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ELEVATION ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1218,350
+4581.1%
0.00%
Q4 2022$03920.0%0.00%
Q3 2022$0
-100.0%
3920.0%0.00%
Q2 2022$1,0000.0%3920.0%0.00%
Q1 2022$1,0003920.00%
Other shareholders
ELEVATION ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,370,142$3,602,6163.79%
Aisling Capital Management LP 2,834,910$4,309,0632.11%
venBio Partners LLC 2,914,255$4,429,6681.60%
TANG CAPITAL MANAGEMENT LLC 4,000,000$6,080,0000.90%
Velan Capital Investment Management LP 497,299$755,8940.70%
Ikarian Capital, LLC 1,149,490$1,747,2250.28%
Samsara BioCapital, LLC 830,565$1,262,4590.22%
SPHERA FUNDS MANAGEMENT LTD. 900,000$1,368,0000.21%
DAFNA Capital Management LLC 450,000$684,0000.19%
BVF INC/IL 2,312,200$3,514,5440.10%
View complete list of ELEVATION ONCOLOGY INC shareholders